• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, September 7, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Investing in protective gear for health care workers pays off

Bioengineer by Bioengineer
October 9, 2020
in Health
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Risko et al, PLOS ONE, 2020 (CC BY)

Providing adequate personal protective equipment (PPE) for all health care workers around the world requires an initial investment of billions of dollars, but the returns on that investment could be close to 8000% in productivity gains, according to a new study published this week in the open-access journal PLOS ONE by Nicholas Risko of the Johns Hopkins University School of Medicine and colleagues.

As COVID-19 spread around the world in early 2020, even resource-rich health systems experienced supply shortages of PPE to protect frontline health care workers. Over 80% of the world’s population lives in low- and middle-income countries (LMICs) where fragile health systems with few resources make health care workers particularly vulnerable to PPE shortages and COVID-19 infection.

In the new study, researchers calculated the cost of providing PPE to all LMIC health systems and used a model to compare the costs and effects of two PPE use scenarios for all LMICs. Data from the World Health Organization COVID-19 Essential Supplies Forecasting Tool was used, as well as estimates of national mortality and hospitalizations that had been previously calculated and published.

The model predicted that an initial global investment of $9.6 billion U.S. could save the lives of roughly 2.2 million health care workers by providing adequate PPE. This comes out to $59 dollars per case averted and $4,309 per life saved. The benefit to society yields $755.3 billion dollars, or about an 8,000% return. The largest net economic gains would be seen in the East Asia & Pacific region, South Asia, and Sub-Saharan Africa. In addition, the study shows that scaling up the provision of PPE is a required component of national strategy if the health care workforce is to be protected.

The authors add: “This study predicts the impact of supplying front-line health care workers in low and middle-income countries with protective equipment during the COVID-19 pandemic. Our central finding is that a small upfront investment will save many lives and provide a substantial economic return, whereas neglecting to protect health care workers risks heavy losses due to illness and death.”

###

Citation: Risko N, Werner K, Offorjebe OA, Vecino-Ortiz AI, Wallis LA, Razzak J (2020) Cost-effectiveness and return on investment of protecting health workers in low- and middle-income countries during the COVID-19 pandemic. PLoS ONE 15(10): e0240503. https://doi.org/10.1371/journal.pone.0240503

Funding: The authors received no specific funding for this work.

Competing Interests: The authors have declared that no competing interests exist. All authors have completed the ICMJE uniform disclosure form at http://www.icmje.org/coi_disclosure.pdf and declare: no support from any organization for the submitted work; no financial relationships with any organizations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

In your coverage please use this URL to provide access to the freely available article in PLOS ONE: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0240503

Media Contact
Kim Polyniak
[email protected]

Related Journal Article

http://dx.doi.org/10.1371/journal.pone.0240503

Tags: Medicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

Tackling Ageism: Nurse Education Intervention Proven Effective

September 7, 2025

Childhood Trauma, HIV, and Women’s Mental Health Insights

September 7, 2025

9-Fluorenone Sulfonamides: Dual Inhibitors of SARS-CoV-2 Proteases

September 7, 2025

Shikonin Blocks EMT in Glioblastoma via p53 Activation

September 7, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    150 shares
    Share 60 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • First Confirmed Human Mpox Clade Ib Case China

    55 shares
    Share 22 Tweet 14
  • A Laser-Free Alternative to LASIK: Exploring New Vision Correction Methods

    47 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Zidesamtinib Demonstrates Lasting Efficacy in ROS1 TKI-Pretreated NSCLC, Including Cases with CNS Involvement and ROS1 G2032R Mutations

Crizotinib Does Not Enhance Disease-Free Survival in Resected Early-Stage ALK-Positive NSCLC

FLAURA2 Trial Demonstrates Enhanced Overall Survival with Osimertinib and Chemotherapy in EGFR-Mutated Advanced NSCLC

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.